Search results for: understanding-and-addressing-methamphetamines-part-1-5

This webinar is an introduction to methamphetamines.  It will cover a variety of topics from description of methamphetamines, pharmacology, and reasons for use.  It will also include special populations and evidence based practices.   Goal:  Increase knowledge about methamphetamines and what works for treatment   Objectives: State statistics for methamphetamines locally and nationally Define stimulant drug Describe methamphetamines, withdrawal, and long term effects List at least 5 reasons for use Describe the routes of administration for methamphetamines including oral, snorting, injecting, and booty bumping List special issues for women and methamphetamines List special issues for MSM (Men who have sex with men) Define evidence-based practice and describe 3 evidence-based practices for methamphetamines Part 2 How do you use methamphetamines? Special Issues for women and MSM Treatment:  Evidence-Based Practices   This course is generally three-hours in length, delivered in two segments (1.5 hours each), therefore, participants are required to attend both segments to attain a 'Certificate of Completion'.   This webinar series is provided under New York State Office of Alcoholism and Substance Abuse Services (OASAS) Education and Training. Provider Certification Number (115) Training under a New York State OASAS Provider Certification is acceptable for meeting all or part of the CASAC/CPP/CPS education and training requirements.   Group Registration: If your agency has a group of people (applies to group of people that will watch the webinar together from one access point) during a live broadcast, then the person registering the group must provide us with the names and their respective email addresses within the group to ensure that everyone fills out an evaluation.

This webinar is an introduction to methamphetamines.  It will cover a variety of topics from description of methamphetamines, pharmacology, and reasons for use.  It will also include special populations and evidence based practices.   Goal:  Increase knowledge about methamphetamines and what works for treatment   Objectives: State statistics for methamphetamines locally and nationally Define stimulant drug Describe methamphetamines, withdrawal, and long term effects List at least 5 reasons for use Describe the routes of administration for methamphetamines including oral, snorting, injecting, and booty bumping List special issues for women and methamphetamines List special issues for MSM (Men who have sex with men) Define evidence-based practice and describe 3 evidence-based practices for methamphetamines Part 1 Epidemiology What is it? Pharmacology   This course is generally three-hours in length, delivered in two segments (1.5 hours each), therefore, participants are required to attend both segments to attain a 'Certificate of Completion'.   This webinar series is provided under New York State Office of Alcoholism and Substance Abuse Services (OASAS) Education and Training. Provider Certification Number (115) Training under a New York State OASAS Provider Certification is acceptable for meeting all or part of the CASAC/CPP/CPS education and training requirements.   Group Registration: If your agency has a group of people (applies to group of people that will watch the webinar together from one access point) during a live broadcast, then the person registering the group must provide us with the names and their respective email addresses within the group to ensure that everyone fills out an evaluation.

To increase knowledge of methamphetamine use in West Virginia. Objectives: 1) Review epidemiology of methamphetamine use in West Virginia; 2) Identify at least 3 reasons why people may use methamphetamines; 3) List at least 3 characteristics of methamphetamines; 4) State 3 perceived benefits of methamphetamines; 5) Describe at least 4 long-term effects of methamphetamines; 6) Define the modes of administration; 7) List at least one pro and one con for each mode of administration; 8) Define the term "evidence-based treatment"; 9) List at least 2 evidence-based treatments for methamphetamine use disorder; and 10) State at least 3 harm reduction techniques for methamphetamine use.

To increase knowledge of methamphetamine use in West Virginia. Objectives: 1) Review epidemiology of methamphetamine use in West Virginia; 2) Identify at least 3 reasons why people may use methamphetamines; 3) List at least 3 characteristics of methamphetamines; 4) State 3 perceived benefits of methamphetamines; 5) Describe at least 4 long-term effects of methamphetamines; 6) Define the modes of administration; 7) List at least one pro and one con for each mode of administration; 8) Define the term “evidence-based treatment”; 9) List at least 2 evidence-based treatments for methamphetamine use disorder; and 10) State at least 3 harm reduction techniques for methamphetamine use.

Want to learn more about Methamphetamine? Need resources to share with your colleagues and clients? SAMHSA just released a list of new resources regarding Methamphetamines. Learn about the rise of...

This course will review crystal meth in the MSM community, describe routes of administration, reasons why MSM use it, treatment options, and barriers to treatment.

  Mary McCarty-Arias, M.A. Research Project Manager Division of Substance Use Disorders New York State Psychiatric Institute Department of Psychiatry, Columbia University Medical Center This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression.

Mary McCarty-Arias, M.A. Research Project Manager Division of Substance Use Disorders New York State Psychiatric Institute Department of Psychiatry, Columbia University Medical Center This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression.  

Mary McCarty-Arias, M.A. Research Project Manager Division of Substance Use Disorders New York State Psychiatric Institute Department of Psychiatry, Columbia University Medical Center   This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression.

Crystal methamphetamine use has increased among MSM of Color in New York City in the past few years. This webinar will introduce participants to crystal methamphetamine use among MSM. This webinar will introduce participants to crystal methamphetamine use among MSM. It will describe crystal meth, reasons why MSM of Color are using it, the effect of crystal meth on HIV, routes of administration, pharmacology, and treatment options.

Methamphetamines – A Growing Trend in the Rio Grande Valley (RGV) Presented by: Hildebrando Mireles III, MA, LPC-S, LCDC-I, PhD Candidate DATE: February 11, 2022 TIME: 2:00pm to 4:00pm CT LOCATION: Zoom  2022 Earn Certificate of Attendance and 2 Free CEUs toward: Certified Rehabilitation Counselor (CRC)- (Non-Ethics) Licensed Professional Counselor (LPC)- (Non-Ethics) Licensed Chemical Dependency Counselor (LCDC)- (Non-Ethics) Please register in advance for this event by clicking this link:  https://utrgv.zoom.us/meeting/register/tZAsdu-opjkvHda-E-1FmaMX62H_U2p1R7QO This event is part of the spring lecture series of the Addiction Resource Center in the School of Rehabilitation Services and Counseling at the University of Texas at Rio Grande Valley (UTRGV), an Educational Consortium partner with the South Southwest Addiction Technology Transfer Center.  For more information please contact Fidencio Mercado at [email protected] or [email protected] 

This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression. This training meets the requirements for two renewal hours (CASAC, CPP, CPS) and two initial hours (CPP, CPS) through New York State’s Office of Addiction Services and Supports (NYS OASAS).

Marcela Smid, MD, MA, M.S,, Assistant Professor of Maternal-Fetal Medicine, University of Utah Health This presentation will address the impact of methamphetamine use during pregnancy on maternal and fetal outcomes. It will also cover current evidence to assist in treatment of women using methamphetamine during pregnancy.     Objectives Overview of evidence-based interventions for pregnant women using methamphetamines.  Discuss perinatal impact of methamphetamine use including maternal, fetal, and infant outcomes.

This course will review crystal meth in the MSM community, describe routes of administration, reasons why MSM use it, treatment options, and barriers to treatment.

This is the 3rd session in the Women and Stimulant Use Project ECHO series. The series will utilize a Project ECHO format to provide case-based learning and consultation for substance use and other health care providers working with women who use stimulants. Using the Zoom videoconferencing platform, providers will be able to connect directly with leading experts in the field to build their capacity to provide evidence-based care. Each 90-minute session will include a brief didactic presentation and an interactive discussion on two de-identified client cases.  Mamas, Munchkins, and Methamphetamines will address the impact of methamphetamine use during pregnancy on maternal and fetal outcomes. And will cover current evidence for treatment of methamphetamine use during pregnancy will be addressed. Objectives Overview of evidence-based interventions for pregnant women using methamphetamines.  Discuss perinatal impact of methamphetamine use including maternal, fetal, and infant outcomes.

The Mid-America Mountain Plains and the South Southwest Regional Addiction Technology Transfer Center are hosting the Women and Stimulants ECHO Series. This series will utilize a Project ECHO format to provide case-based learning and consultation for substance use and other health care providers working with women who use stimulants, including cocaine and methamphetamines. Using the Zoom videoconferencing platform, providers will be able to connect directly with leading experts in the field to build their capacity to provide evidence-based care. Each 90-minute session will include a brief didactic presentation and an interactive discussion on two de-identified client cases.  Registration is limited to 100 participants per session. Please register for each individual session by clicking on the session titles below. See webpage for detailed descriptions of the sessions and information regarding CEs. To learn more about what a Project ECHO session is like, view this brief video.  Woman and Stimulant Use: Mamas, Munchkins, and Methamphetamines October 30, 2019 from 11:30am- 1:00pm CT Marcela Smid, MD, MA, MS, Assistant Professor of Maternal-Fetal Medicine, University of Utah Health This presentation will address the impact of methamphetamine use during pregnancy on maternal and fetal outcomes. And will cover current evidence for treatment of methamphetamine use during pregnancy will be addressed. Register Here! 

Crystal methamphetamine use has increased among MSM of color in New York City in the past few years. This webinar will introduce participants to crystal methamphetamine use among MSM. It will describe crystal meth, reasons why MSM of color are using it, the effect of crystal meth on HIV, routes of administration, pharmacology, and treatment options.

This one day course is similar to the half day but includes more exercises and discussion. It will review crystal meth in the MSM community, describe routes of administration, reasons why MSM use it, treatment options, and barriers to treatment.

...strategies for facing addiction in America. Please join Dr. Clark on the   webinar! This SG Report proposes a comprehensive and widely-applicable framework for addressing substance use, misuse, and dependence in America....

OVERALL DESCRIPTION The increasing use of electronic vaporizing devices (i.e. “vaping”), especially among youth and young adults, presents a challenge for public health and substance use treatment stakeholders. The decline in tobacco product use since the 1990s has been one of the great public health success stories in recent years. However, rising rates of vaping threaten to undo that success. Vaping of other substances, such as cannabis, is also on the rise and presents a related challenge. This two-part webinar series will discuss how, why, and to what extent vaping rates have increased across different populations and review effective public health and treatment responses to vaping. WEBINAR DESCRIPTION This webinar will examine evidence-based and promising public health policy recommendations and treatment strategies for addressing and reducing vaping use. It will also review the gaps in knowledge that still exist due to the recency of vaping as a major public health issue. Despite these gaps and lack of comprehensive treatment guidelines, there are promising programs such as CATCH My Breath and smokeSCREEN, as well as the potential for pharmacological interventions when warranted. In addition to discussing these strategies, the webinar will review potential public health policies for addressing environmental factors related to risk of vaping. It will also summarize recent federal and state regulatory actions to address vaping. Lastly, the webinar will provide a small group discussion opportunity for participants to share their experiences addressing vaping. LEARNING OBJECTIVES By the end of this webinar, participants will be able to: Explain the current evidence base for effective vaping interventions Understand potentially promising programs and the importance of pilot programs Summarize the public health response to vaping and opportunities for improvement PRESENTERS Josh Esrick, MPP,  is a Senior Policy Analyst with Carnevale Associates. Josh has extensive experience in substance use prevention; researching, writing, and presenting on best practice and knowledge development publications, briefs, and reference guides; and developing and providing training and technical assistance to numerous organizations at the Federal, state, and local levels.He developed numerous SAMHSA Center for the Application of Prevention Technologies’ (CAPT) products on strategies to prevent opioid misuse and overdose, risk and protective factors for substance use, youth substance use prevention strategies, youth substance use trends, emerging substance use trends, the potential regulations surrounding marijuana legalization, as well as numerous other topics.     Emily Patton, MSc, PgDip, holds a Master of Science in Abnormal and Clinical Psychology from Swansea University and a Postgraduate Degree in Criminology and Criminal Justice from the University of Edinburgh. She offers significant professional experience in the fields of public policy development and analysis, criminal justice research, data collection and analysis, program development, and performance management.                  

DESCRIPTION The aspects of life that influence a person’s health, including their likelihood of engaging in risky behavior such as substance use, are numerous and varied. They range from very immediate, personal characteristics all the way up to overarching societal trends and conditions. The Social Determinants of Health are these larger social or environmental aspects that influence us, such as the economic status of the neighborhoods in which we live, our access to quality health care services, and the amount of discrimination we face. This webinar will introduce and discuss the social determinants of health in greater detail and explain which aspects have been found to be significantly linked to substance use. It will also discuss how we can follow a public health approach to prevention and how we can use environmental strategies to address them. LEARNING OBJECTIVES Explain what the social determinants of health are and how they relate to the socio-ecological model of prevention Discuss the social determinants of health linked to increased risk of substance use Overview of the public health approach to prevention and the role of environmental strategies Examine the research on examples of environmental strategies PRESENTER Josh Estrick, MPP, is a Senior Policy Analyst with Carnevale Associates. Josh has extensive experience in substance use prevention; researching, writing, and presenting on best practice and knowledge development publications, briefs, and reference guides; and developing and providing training and technical assistance to numerous organizations at the Federal, state, and local levels. He developed numerous SAMHSA Center for the Application of Prevention Technologies’ (CAPT) products on strategies to prevent opioid misuse and overdose, risk and protective factors for substance use, youth substance use prevention strategies, youth substance use trends, emerging substance use trends, the potential regulations surrounding marijuana legalization, as well as numerous other topics.   Emily Patton, MSc, PgDip, holds a Masters of Science in Abnormal and Clinical Psychology from Swansea University and a Postgraduate Degree in Criminology and Criminal Justice from the University of Edinburgh. She offers significant professional experience in the fields of public policy development and analysis, criminal justice research, data collection and analysis, program development, and performance management.   This webinar is a collaboration between the Central East ATTC, the Central East MHTTC, and the Central East PTTC.

  Please Note: This training is focused on changes to the DSM-5-TR that address substance use disorders (SUD).   DESCRIPTION: Participants will receive a 2-hour review of the changes specific to substance use disorders (SUD) that were made to the DSM-5-TR. This training will cover new clinical conditions, new diagnoses, and updated language that supports health equity and culturally appropriate service delivery. We will also discuss new coding procedures and what resources are available to help clinicians transition from using the DSM-5 to the DSM-5-TR. This training is for all levels but is especially important for providers who are new to diagnosing and/or those who haven’t yet reviewed the DSM-5-TR. **Please bring your new DSM 5-TR or your quick guide to the training.**     LEARNING OBJECTIVES: Describe general changes to the DSM-5-TR including substance use diagnosis. Discuss new clinical conditions and how to use the decision tree. Identify updated inclusive language in the DSM-5-TR and how it supports health equity.     CERTIFICATES: Registrants who fully attend this event or training will receive a certificate of attendance via email within two weeks after the event or training.      TRAINER: Jennifer Haywood, LISW-S, LICDC-CS Jennifer has been training helping professionals since 1998. Her specialties include diagnosis, motivational interviewing, addictions focus topics, drug free workplace trainings, ethics, and supervision. Jennifer goes to agencies state-wide to train staff in treatment models in order to help their clients and trained all the behavioral health and medical social workers at Nationwide Children's Hospital in Motivational Interviewing in 2011/2012. Currently, Jennifer is teaching at OSU in the MSW and BSSW programs, focusing on the addictions minor the university is offering, clinical diagnosing and motivational interviewing. Jennifer has a private practice in Worthington, Ohio where she specializes in treating addicts and alcoholics, families of addicts and alcoholics, depression, anxiety, post-partum women, womens' issues, adolescent issues (14+ only), and relationship struggles. Jennifer's 24 years of experience in the addictions field allow her to assess, diagnose and treat clients with the expertise needed.  Jennifer is currently open for new clients and can guide anyone with questions about the right "fit" when choosing one of the clinicians she supervises.     The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.

  DESCRIPTION: Participants will receive a 2-hour review of the changes specific to substance use disorders (SUD) that were made to the DSM-5-TR. This training will cover new clinical conditions, new diagnoses, and updated language that supports health equity and culturally appropriate service delivery. We will also discuss new coding procedures and what resources are available to help clinicians transition from using the DSM-5 to the DSM-5-TR. This training is for all levels but is especially important for providers who are new to diagnosing and/or those who haven’t yet reviewed the DSM-5-TR.     LEARNING OBJECTIVES: Describe general changes to the DSM-5-TR including substance use diagnosis. Discuss new clinical conditions and how to use the decision tree. Identify updated inclusive language in the DSM-5-TR and how it supports health equity.       TRAINER: Jennifer Haywood, LISW-S, LICDC-CS Jennifer has been training helping professionals since 1998. Her specialties include diagnosis, motivational interviewing, addictions focus topics, drug free workplace trainings, ethics, and supervision. Jennifer goes to agencies state-wide to train staff in treatment models in order to help their clients and trained all the behavioral health and medical social workers at Nationwide Children's Hospital in Motivational Interviewing in 2011/2012. Currently, Jennifer is teaching at OSU in the MSW and BSSW programs, focusing on the addictions minor the university is offering, clinical diagnosing and motivational interviewing. Jennifer has a private practice in Worthington, Ohio where she specializes in treating addicts and alcoholics, families of addicts and alcoholics, depression, anxiety, post-partum women, womens' issues, adolescent issues (14+ only), and relationship struggles. Jennifer's 24 years of experience in the addictions field allow her to assess, diagnose and treat clients with the expertise needed.  Jennifer is currently open for new clients and can guide anyone with questions about the right "fit" when choosing one of the clinicians she supervises.     The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.